Haw Par logo

H02 - Haw Par Share Price

S$12.35 -0.4  -2.8%

Last Trade - 9:12am

Sector
Healthcare
Size
Mid Cap
Market Cap £1.59bn
Enterprise Value £1.35bn
Revenue £143.3m
Position in Universe 551st / 5984
Bullish
Bearish
Unlock H02 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

H02 Revenue Unlock H02 Revenue

Net Income

H02 Net Income Unlock H02 Revenue

Normalised EPS

H02 Normalised EPS Unlock H02 Revenue

PE Ratio Range

H02 PE Ratio Range Unlock H02 Revenue

Dividend Yield Range

H02 Dividend Yield Range Unlock H02 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
H02 EPS Forecasts Unlock H02 Revenue
Profile Summary

Haw Par Corporation Limited is engaged in manufacturing, marketing and trading healthcare products; providing leisure-related goods and services, and investing in properties and securities. The principal activities of the Company are licensing of the Tiger trademarks and owning investments for long-term holding purposes. Its segments are Healthcare and products; Leisure products and services; Property rental, and Investments. The Healthcare division manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. The Leisure division provides family and tourist oriented leisure alternatives in the form of oceanariums. The Property division owns and leases out various investment properties in the Asean region. The Investment division engages in investing activities in quoted and unquoted securities in the Asia region. Its product extensions include Tiger Balm Medicated Plaster, Tiger Balm Joint Rub, and Tiger Balm Neck and Shoulder Rub.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated December 31, 1969
Public Since January 2, 1979
No. of Shareholders: 18,666
No. of Employees: 595
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Singapore Exchange Securities Trading Ltd
Shares in Issue 221,091,173
Free Float (0.0%)
Eligible for
ISAs
SIPPs
H02 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for H02
Upcoming Events for H02
Friday 17th April, 2020 Estimate
Haw Par Corporation Ltd Annual Shareholders Meeting
Similar to H02
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.